Increased diisopropylfluorophosphate-induced toxicity in μ-opioid receptor knockout mice

Journal of Neuroscience Research

Volumn 78, Issue 2, 2004, Pages 259-267

  Tien, Lu Tai ^a   Fan, Lir Wan ^a   Ma, Tangeng ^a   Loh, Horace H ^b   Ho, Ing Kang ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

opioid receptors; Autoradiography; Diisopropylfluorophosphate; M1 and M2 muscarinic receptors

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE INHIBITOR; DYFLOS; MU OPIATE RECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; PIRENZEPINE; QUINUCLIDINYL BENZILATE; SODIUM CHLORIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; KNOCKOUT MOUSE; LOCOMOTION; MALE; MASTICATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; TREMOR;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; ISOFLUROPHATE; MALE; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, MUSCARINIC; RECEPTORS, OPIOID, MU; TREMOR;

EID: 4744366773     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20259     Document Type: Article

References (50)

1. Bonner TI. 1992. Domains of muscarinic acetylcholine receptors that confer specificity of G protein coupling. Trends Pharmacol Sci 13:48-50.
2. Buccafusco JJ, Zhang LC, Shuster LC, Jonnala RR, Gattu M. 2000. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Res 852:76-83.
3. Bushnell PJ, Padilla SS, Ward T, Pope CN, Olszyk VB. 1991. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J Pharmacol Exp Ther 256:741-750.
4. Bymaster FP, Carter PA, Zhang L, Falcone JF, Stengel PW, Cohen ML, Shannon HE, Gomeza J, Wess J, Felder CC. 2001. Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice. Life Sci 68:2473-2479.
5. Connor JD, Rossi GV, Baker WW. 1966. Analysis of the tremor induced by injection of cholinergic agents into the caudate nucleus. Int J Neuropharmacol 5:207-216.
6. Console S, Ladinsky H, Vinci R, Palazzi E, Wang JX. 1987. An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum. Biochem Pharmacol 36:3075-3077.
7. Cousins MS, Finn M, Trevitt J, Carriero DL, Conlan A, Salamone JD. 1999. The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements. Pharmacol Biochem Behav 62:439-447.
8. Douglas CL, Baghdoyan HA, Lydic R. 2002. Prefrontal cortex acetylcholine release, EEG slow waves, and spindles are modulated by M2 autoreceptors in C57BL/6J mouse. J Neurophysiol 87:2817-2822.
9. Feldman RS, Mayer JS, Quenzer LF. 1997. Principles of neuropsychopharmacology. Sunderland MA: Sinauer Associates. p 237.
10. Fernando JC, Hoskins B, Ho IK. 1984. Effect on striatal dopamine metabolism and differential motor behavioral tolerance following chronic cholinesterase inhibition with diisopropylfluorophosphate. Pharmacol Biochem Behav 20:951-957.
11. Feuerstein TJ, Gleichauf O, Peckys D, Landwehrmeyer GB, Scheremet R, Jackisch R. 1996. Opioid receptor-mediated control of acetylcholine release in human neocortex tissue. Naunyn Schmiedebergs Arch Pharmacol 354:586-592.
12. Fiserova M, Consolo S, Krsiak M. 1999. Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study. Psychopharmacology 142:85-94.
13. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. New York: Academic Press.
14. Gattu M, Wei J, Pauly JR, Urbanawiz S, Buccafusco JJ. 1997. Increased expression of M2 muscarinic receptor mRNA and binding sites in the rostral ventrolateral medulla of spontaneously hypertensive rats. Brain Res 756:125-132.
15. Gazyakan E, Hennegriff M, Haaf A, Landwehrmeyer GB, Feuerstein TJ, Jackisch R. 2000. Characterization of opioid receptor types modulating acetylcholine release in septal regions of the rat brain. Naunyn Schmiedebergs Arch Pharmacol 362:32-40.
16. Gomeza J, Zhang L, Kostenis E, Felder CC, Bymaster FP, Brodkin J, Shannon H, Xia B, Duttaroy A, Deng CX, Wess J. 2001. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. Life Sci 68:2457-2466.
17. Gordon CJ. 1993. Acute and delayed effects of diisopropylfluorophosphate on body temperature, heart rate, and motor activity in the awake, unrestrained rat. J Toxicol Environ Health 39:247-260.
18. Green JP, Glick SD, Crane AM, Szilagyi PI. 1976. Acute effects of morphine on regional brain levels of acetylcholine in mice and rats. Eur J Pharmacol 39:91-99.
19. Harsing LG Jr, Zigmond MJ. 1998. Postsynaptic integration of cholinergic and dopaminergic signals on medium-sized GABAergic projection neurons in the neostriatum. Brain Res Bull 45:607-613.
20. Hersch SM, Gutekunst CA, Rees HD, Heilman CJ, Levey AI. 1994. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14:3351-3363.
21. Hozumi S, Nakagawasai O, Tan-No K, Niijima F, Yamadera F, Murata A, Arai Y, Yasuhara H, Tadano T. 2003. Characteristics of changes in cholinergic function and impairment of learning and memory-related behavior induced by olfactory bulbectomy. Behav Brain Res 138:9-15.
22. Huhne EC, Birdsall NJ, Buckley NJ. 1990. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673.
23. Ikarashi Y, Takahashi A, Ishimaru H, Arai T, Maruyama Y. 1997. Relations between the extracellular concentrations of chorine and acetylcholine in rat striatum. J Neurochem 69:1246-1251.
24. Imperato A, Obinu MC, Casu MA, Mascia MS, Carta G, Gessa GL. 1996. Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. Eur J Pharmacol 302:21-26.
25. Kawaguchi Y. 1992. Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. J Neurophysiol 67:1669-1682.
26. Koshimura K, Miwa S, Lee K, Hayashi Y, Hasegawa H, Hamahata K, Fujiwara M, Kimura M, Itokawa Y. 1990. Effects of choline administration on in vivo release and biosynthesis of acetylcholine in the rat striatum as studied by in vivo brain microdialysis. J Neurochem 54:533-539.
27. Lalley PM, Rossi GV, Baker WW. 1973. Tremor induction by intracaudate injections of bretylium, tetrabenazine, or mescaline: functional deficits in caudate dopamine. J Pharm Sci 62:1302-1307.
28. Lapchak PA, Araujo DM, Collier B. 1989. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat. Neuroscience 31:313-325.
29. Lim DK, Hoskins B, Ho IK. 1983. Assessment of diisopropylfluorophosphate (DFP) toxicity and tolerance in rats. Res Commun Chem Pathol Pharmacol 39:399-418.
30. Lim DK, Fernando JC, Hoskins B, Ho IK. 1987. Quantitative assessment of tolerance development to diisopropylfluorophosphate. Pharmacol Biochem Behav 26:281-286.
31. Lim DK, Ito Y, Hoskins, Ho IK. 1988. Effects of acute and subacute administration of bicuculline on dopamine and muscarinic receptors in rat brain. Brain Res Bull 21:21-24.
32. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN. 1998. Mu-opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54:321-326.
33. Ma T, Cai Z, Wellman SE, Ho IK. 2001. A quantitative histochemistry technique for measuring regional distribution of acetylcholinesterase in the brain using digital scanning densitometry. Anal Biochem 296:18-28.
34. Mattio TG, Richardson JS, Giacobini E. 1984. Effects of DFP on iridic metabolism and release of acetylcholine and on pupillary function in the rat. Neuropharmacology 23:1207-1214.
35. Padmanabha Pillai N, Ramaswamy S, Gopalakrishnan V, Ghosh MN. 1982. Effect of cholinergic drugs on acute and chronic morphine dependence. Arch Int Pharmacodyn Ther 257:146-154.
36. Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G. 2000. Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci 20:RC69.
37. Prendergast MA, Terry AV Jr, Buccafusco JJ. 1997. Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning. Psychopharmacology 129:183-191.
38. Sakai M, Fukuyama H, Sato K, Kudoh I. 2002. Effects of fentanyl on acetylcholine release from hippocampus and righting reflex in rat: an in vivo brain microdialysis study. Masui 51:118-123.
39. Schwab C, Bruckner G, Rothe T, Castellano C, Oliverio A. 1992. Autoradiography of muscarinic cholinergic receptors in cortical and subcortical brain regions of C57BL/6 and DBA/2 mice. Neurochem Res 17:1057-1062.
40. Shapovalova KB. 2002. Muscarinic receptors of the neostriatum-their role in controlling operant behavior in dogs. Neurosci Behav Physiol 32:389-399.
41. Sivam SP, Nabeshima T, Lim DK, Hoskins B, Ho IK. 1983. Diisopropylfluorophosphate and GABA synaptic function: effect on levels, enzymes, release and uptake in the rat striatum. Res Commun Chem Pathol Pharmacol 42:51-60.
42. Smolen A, Smolen TN, Wehner JM, Collins AC. 1985. Genetically determined differences in acute responses to diisopropylfluorophosphate. Pharmacol Biochem Behav 22:623-630.
43. Taguchi K, Hagiwara Y, Suzuki Y, Kubo T. 1993. Effects of morphine on release of acetylcholine in the rat striatum: an in vivo microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 347:9-13.
44. Tien LT, Park Y, Fan LW, Ma T, Lob HH, Ho IK. 2003. Increased dopamine D2 receptor binding and enhanced aponiorphine-induced locomotor activity in mu-opioid receptor knockout mice. Brain Res Bull 61:109-115.
45. van der Zee EA, Luiten PG. 1999. Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog Neurobiol 58:409-471.
46. Wainer BH, Bolam JP, Freund TF, Henderson Z, Totterdell S, Smith AD. 1984. Cholinergic synapses in the rat brain: a correlated light and electron microscopic immunohistochemical study employing a monoclonal antibody against choline acetyltransferase. Brain Res 308:69-76.
47. Weiler M. 1989. Muscarinic modulation of endogenous acetylcholine release in rat neostriatal slices. J Pharmacol Exp Ther 250:617-623.
48. Wess J, Duttaroy A, Gomeza J, Zhang W, Yamada M, Felder CC, Bernardini N, Reeh HW. 2003. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice. Life Sci 72:2047-2054.
49. Wilson CJ, Chang HT, Kitai ST. 1990. Firing patterns and synaptic potentials of identified giant aspiny interneurons in the rat neostriatum. J Neurosci 10:508-519.
50. Woolf NJ. 1991. Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37:475-524.